SEC 13F Intelligence

Almitas Capital LLC / AMLX

Almitas Capital LLC’s Amylyx Pharmaceuticals Inc Position

Does Almitas Capital LLC own Amylyx Pharmaceuticals Inc (AMLX)? Yes — 2.12M shares worth $30M (+6.67% of its 13F portfolio) as of Q1 2026.

Position Value
$30M
Q1 2026
Shares
2.12M
% of Portfolio
+6.67%
Quarters Held
8
currently held

Position History AMLX

Reported value by quarter
Q2 ’24: $4MQ2 ’24Q3 ’24: $6MQ3 ’24Q4 ’24: $8MQ4 ’24Q1 ’25: $8MQ1 ’25Q2 ’25: $14MQ2 ’25Q3 ’25: $58MQ3 ’25Q4 ’25: $26MQ4 ’25Q1 ’26: $30MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.12M$30M+6.67%
Q4 20252.12M$26M+5.65%
Q3 20254.25M$58M+6.66%
Q2 20252.12M$14M+3.43%
Q1 20252.12M$8M+2.49%
Q4 20242.03M$8M+1.68%
Q3 20241.99M$6M+2.28%
Q2 20241.90M$4M+1.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Almitas Capital LLC’s full portfolio or all institutional holders of AMLX.